Prince Pharmaceutical Co., Ltd.
Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufena… Read more
Prince Pharmaceutical Co., Ltd. (6935) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.002x
Based on the latest financial reports, Prince Pharmaceutical Co., Ltd. (6935) has a cash flow conversion efficiency ratio of -0.002x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-1.62 Million) by net assets (NT$740.69 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Prince Pharmaceutical Co., Ltd. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Prince Pharmaceutical Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Prince Pharmaceutical Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Prince Pharmaceutical Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TWL Holdings Bhd
KLSE:7079
|
-0.025x |
|
Replenish Nutrients Holding Corp.
F:7KE
|
-0.023x |
|
Peace & Living PCL
BK:PEACE
|
-0.013x |
|
Alton Sports Co.Ltd
KQ:123750
|
0.190x |
|
TVI Pacific Inc
PINK:TVIPF
|
0.000x |
|
Barrister Energy LLC
PINK:CJAX
|
-0.003x |
|
Choice Development Inc
TW:9929
|
0.058x |
|
Inswave Systems Co., Ltd.
KQ:450520
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Prince Pharmaceutical Co., Ltd. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Prince Pharmaceutical Co., Ltd. from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$722.06 Million | NT$46.21 Million | 0.064x | -20.70% |
| 2023-12-31 | NT$774.47 Million | NT$62.50 Million | 0.081x | -42.03% |
| 2022-12-31 | NT$658.38 Million | NT$91.65 Million | 0.139x | +98.14% |
| 2021-12-31 | NT$602.87 Million | NT$42.36 Million | 0.070x | +20341.67% |
| 2020-12-31 | NT$610.77 Million | NT$-212.00K | 0.000x | -102.67% |
| 2019-12-31 | NT$619.62 Million | NT$8.05 Million | 0.013x | -- |